| Income Statement | 2025-09-30 | 2025-06-30 | ||
|---|---|---|---|---|
| Research and development | 50,334 | - | ||
| Selling, general and administrative | 17,362 | - | ||
| Total operating expenses | 67,696 | - | ||
| Loss from operations | -67,696 | - | ||
| Interest income | 6,412 | - | ||
| Interest expense | 917 | - | ||
| Other income (expense) | -18 | - | ||
| Total other income (expense), net | 5,477 | - | ||
| Loss before income taxes | -62,219 | - | ||
| Income tax expense | 102 | - | ||
| Net loss | -62,321 | -55,247 | ||
| Foreign currency translation adjustments | - | -15 | ||
| Unrealized gain on marketable securities | - | -247 | ||
| Total other comprehensive loss | - | -262 | ||
| Comprehensive loss | - | -55,509 | ||
| Earnings per share, basic, total | -1.77 | -1.58 | ||
| Earnings per share, diluted, total | -1.77 | -1.58 | ||
| Weighted average number of shares outstanding, basic, total | 35,178,691 | 35,024,592 | ||
| Weighted average number of shares outstanding, diluted, total | 35,178,691 | 35,024,592 | ||
Disc Medicine, Inc. (IRON)
Disc Medicine, Inc. (IRON)